These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21480251)

  • 1. Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy.
    Baehner FL; Lee M; Demeure MJ; Bussey KJ; Kiefer JA; Barrett MT
    J Surg Oncol; 2011 May; 103(6):563-73. PubMed ID: 21480251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.
    Pedraza V; Gomez-Capilla JA; Escaramis G; Gomez C; Torné P; Rivera JM; Gil A; Araque P; Olea N; Estivill X; Fárez-Vidal ME
    Cancer; 2010 Jan; 116(2):486-96. PubMed ID: 20029976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic applications of gene expression signatures in breast cancer.
    Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
    Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lost in translation--prognostic signatures for breast cancer.
    Pusztai L
    Nat Clin Pract Oncol; 2008 Jul; 5(7):363. PubMed ID: 18583992
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histopathologic diagnosis of luminal and basal type breast cancer].
    Sarcević B
    Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer.
    Paik S; Kim CY; Song YK; Kim WS
    Nat Clin Pract Oncol; 2005 May; 2(5):246-54. PubMed ID: 16264960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is genetic signature enough?
    Tez M
    J Surg Oncol; 2011 Nov; 104(6):707. PubMed ID: 21538363
    [No Abstract]   [Full Text] [Related]  

  • 9. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of gene expression profile signatures in early-stage breast cancer.
    Desmedt C; Sotiriou C; Piccart-Gebhart MJ
    Cancer Invest; 2009 Jan; 27(1):1-10. PubMed ID: 19191098
    [No Abstract]   [Full Text] [Related]  

  • 11. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genomic based approach to individualized cancer therapy].
    Isomura M; Miki Y
    Nihon Rinsho; 2010 Jun; 68(6):1117-20. PubMed ID: 20535965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the science: molecular classifications of breast cancer for clinical diagnostics.
    Robison JE; Perreard L; Bernard PS
    Clin Biochem; 2004 Jul; 37(7):572-8. PubMed ID: 15234238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
    Lancashire LJ; Rees RC; Ball GR
    Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A report of a family affected by a Li-Fraumeni type of syndrome with adrenal cortical carcinoma in an adult. A case].
    Massotti G; Tonolini M; Saibene F; Gattoni F; Uslenghi CM
    Radiol Med; 2000 Mar; 99(3):206-9. PubMed ID: 10879177
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized therapy for breast cancer.
    De Abreu FB; Schwartz GN; Wells WA; Tsongalis GJ
    Clin Genet; 2014 Jul; 86(1):62-7. PubMed ID: 24635704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.